Skadden, Arps, Slate, Meagher & Flom LLP and Affiliates

Human Genome Sciences Announces Unsolicited Offer From Glaxosmithkline

Skadden is representing Human Genome Sciences, Inc. in its unsolicited $2.6 billion acquisition offer from GlaxoSmithKline plc.

BACK TO TOP